Michel Vounatsos vs Richard Paulson | Comparably
Profile Image
VS
Profile Image
Biogen Claimed Company
EMPLOYEE
PARTICIPANTS
193
TOTAL
RATINGS
1682
Karyopharm Therapeutics Claimed Company
This companyis accepting feedback from verified employees
EMPLOYEE
PARTICIPANTS
90
TOTAL
RATINGS
2628

Michel Vounatsos vs Richard Paulson

Michel Vounatsos Biogen's CEO
Michel Vounatsos
Biogen
Top 50%
Top 50% of Similar Size Companies on Comparably
C+
66/100
VS
Richard Paulson Karyopharm Therapeutics' CEO
Richard Paulson
Karyopharm Therapeutics
Top 5%
Top 5% of Similar Size Companies on Comparably
A+
82/100

Biogen vs Karyopharm Therapeutics CEO Comparison Summary

Employees at Biogen rank Michel Vounatsos in the Bottom 35% of CEOs in Boston. Comparatively, employees at Karyopharm Therapeutics rank Richard Paulson in the Top 10% of CEOs in Boston. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.

Michel Vounatsos Biogen's CEO
Michel Vounatsos

CEO of Biogen

BIO: Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.

Richard Paulson Karyopharm Therapeutics' CEO
Richard Paulson

CEO of Karyopharm Therapeutics

BIO: Mr. Paulson was appointed President and Chief Executive Officer of Karyopharm in May 2021 and has served as a member of Karyopharm’s Board of Directors since February 2020. He was previously an Executive Vice President of Ipsen Pharmaceuticals, Inc. and Chief Executive Officer of Ipsen North America, a global biopharmaceutical company focused on innovation and specialty care in areas of oncology, neuroscience and rare diseases, from February 2018 to May 2021. Mr. Paulson previously worked at Amgen for 10 years holding varying leadership positions across Europe and North America, including Vice President and General Manager of Amgen’s U.S. Oncology Business Unit, and prior to that served as the Vice President of Marketing for Amgen’s U.S. Oncology Business, General Manager of Amgen Germany, and General Manager of Amgen Central & Eastern Europe. Prior to Amgen, Mr. Paulson held a number of global leadership positions at Pfizer Inc., including serving as General Manager of Pfizer South Africa and Pfizer Czech Republic. Mr. Paulson also previously held a variety of sales, marketing, and market access roles with increasing seniority at GlaxoWellcome in Canada. Mr. Paulson has an MBA from the University of Toronto, Canada and an undergraduate degree in commerce from the University of Saskatchewan, Canada.

Gender Score

Michel Vounatsos Biogen's CEO
Michel Vounatsos
Biogen
Top 40%
Top 40% of Similar Size Companies on Comparably
B-
Gender

Women at Biogen rated their CEO a B-

Richard Paulson Karyopharm Therapeutics' CEO
Richard Paulson
Karyopharm Therapeutics
Top 5%
Top 5% of Similar Size Companies on Comparably
A+
Gender

Women at Karyopharm Therapeutics rated their CEO an A+

Diversity Score

Michel Vounatsos Biogen's CEO
Michel Vounatsos
Biogen
Top 40%
Top 40% of Similar Size Companies on Comparably
B-
Diversity

Diverse Employees at Biogen rated their CEO a B-

Richard Paulson Karyopharm Therapeutics' CEO
Richard Paulson
Karyopharm Therapeutics
Top 10%
Top 10% of Similar Size Companies on Comparably
A
Diversity

Diverse Employees at Karyopharm Therapeutics rated their CEO an A

Question:
Do you approve of your CEOs management style?

Question:
How would you rate the effectiveness of your CEO to drive business results?

Michel Vounatsos Biogen's CEO
Michel Vounatsos
Biogen
Excellent
0%
Good
0%
Average
0%
Poor
0%
Very Bad
100%

Who Ranks the CEO highest?

At Biogen, employees in the HR department rate Michel Vounatsos the highest. According to employees, Michel Vounatsos' ability to drive business results is Very Bad. At Karyopharm Therapeutics, the IT department's employees rate their CEO highest.

Michel Vounatsos Biogen's CEO
Michel Vounatsos
Biogen
92/100Department - HR
90/100Ethnicity - African American/Black
78/100Tenure - Less than 1 Year
78/100Education - Bachelor's
81/100Experience - 6 to 10 Years
Richard Paulson Karyopharm Therapeutics' CEO
Richard Paulson
Karyopharm Therapeutics
90/100Department - IT
84/100Ethnicity - Caucasian
Tenure - N/A
Education - N/A
90/100Experience - Entry Level